FDA Flags 4.3 Million Tubes of Imported, Character-Branded Toothpaste Over Manufacturing Violations

The Food and Drug Administration has classified a recall of roughly 4.3 million tubes of fluoride toothpaste sold under a cluster of budget and character-branded names, after inspectors found manufacturing problems at the Indian company that made them. The toothpaste, sold almost entirely through third-party listings on Amazon and eBay rather than in stores, included children's varieties decorated with licensed characters such as Barbie, Hot Wheels, Crayola Silly Scents and My Little Pony, alongside ice-cream-flavored and adult whitening lines.

The recall was initiated voluntarily by the manufacturer, Pritam International Private Limited of India, on Sept. 10, and distributed in the United States by Ashtel Studios Inc. of Ontario, California. The FDA's public recall listings show the agency assigned it a Class II designation on Oct. 19, meaning regulators believe exposure to the affected toothpaste could cause temporary or medically reversible harm, a tier below the most serious, life-threatening classification.

What was recalled, and how much

The recall covers roughly 4,298,900 tubes across about 15 labeled varieties sold under several house brands tied to the same manufacturer and distributor: Brush Buddies, evo, BB and ARU. The character-themed tubes aimed at children include Barbie, Hot Wheels, Crayola Silly Scents and My Little Pony Scents anticavity fluoride toothpaste, while a separate line was flavored to taste like vanilla, mint chocolate chip, cookies 'n cream and chocolate ice cream. Adult-oriented versions included whitening formulas with baking soda, gum-health pastes and cavity-protection toothpaste marketed under the ARU and BB names.

The stated reason for the recall, as logged by the FDA, is "deviations from Current Good Manufacturing Practice regulations" — the baseline federal rules that govern how drugs, including over-the-counter fluoride toothpaste, must be produced, tested and documented to ensure consistency and safety. The recall notice does not describe a specific contamination finding or cite any confirmed injuries or illnesses linked to the products.

A pattern of overseas toothpaste recalls

This is not an isolated event. Over the past 18 months, the FDA has classified a string of Class II recalls involving fluoride toothpaste manufactured overseas and distributed in the U.S. under small or little-known labels. An India-based company recalled more than 2 million tubes of Nature Mint and Maximum Security anticavity toothpaste in 2025 over the same category of manufacturing-practice violations, and a separate recall of Colgate and Crest products earlier this year cited insanitary conditions, including rodent activity, at a third-party distribution warehouse rather than at the toothpaste makers themselves.

Darin Detwiler, a food-safety researcher who teaches at Northeastern University's College of Professional Studies and advises the Alliance for Recall Ready Communities, said violations of this kind are rarely about a single bad batch.

"Deviations from cGMPs can compromise the integrity of the entire production process. While a violation might not always result in immediate health threats, when a recall of this size happens, it means the FDA and the company found enough of a potential risk — such as contamination or quality failure — that it wasn't worth gambling with public safety."

Toothpaste containing fluoride is regulated by the FDA as an over-the-counter drug, not simply a cosmetic, which is why manufacturing deviations trigger the same recall and classification process used for prescription medicines. The agency maintains those enforcement actions in a public database, openFDA's drug enforcement system, which is updated on a rolling basis as new classifications are logged.

Who bought it, and why it matters for children

Because the recalled tubes were sold mainly through online marketplace listings rather than pharmacy or grocery shelves, the buyers are harder to reach through the in-store signage or point-of-sale alerts that typically accompany a major-brand recall. Parents who bought inexpensive, character-branded toothpaste for young children online are among those most likely to have the affected products in a bathroom cabinet without realizing the connection to a manufacturing recall rather than a labeling or packaging issue.

The stakes of a manufacturing lapse in a product young children routinely swallow in small amounts are not trivial. Federal toxicology guidance compiled by the Agency for Toxic Substances and Disease Registry notes that children can be exposed to unusually high levels of fluoride if they swallow dental products such as toothpaste, which is why federal guidance advises adults to supervise young children's brushing and limit the amount of toothpaste used. That baseline risk is separate from, and not necessarily increased by, the cGMP violations cited in this recall, but it is part of why regulators hold toothpaste to drug-manufacturing standards in the first place.

What happens next

No retailer-style refund process, such as a point-of-return system at a national chain, applies here, since the products were sold through individual online marketplace listings rather than a single retail chain. Consumers who believe they purchased one of the affected varieties are generally advised, per standard FDA recall practice, to stop using the product and to contact the seller or platform where it was purchased about a return or refund. Anyone who experiences an adverse reaction tied to a recalled drug product, including an over-the-counter item like toothpaste, can file a report with the FDA directly through its MedWatch safety reporting program.

The recall's Class II status means the FDA does not consider the risk to rise to its most urgent tier, and the agency has not ordered a broader market withdrawal of fluoride toothpaste generally. But coming on the heels of several similar actions against small, overseas-manufactured oral care brands sold directly to consumers online, it adds to a developing regulatory record on how closely imported personal-care products marketed through e-commerce platforms are being manufactured to the standards federal law requires, and how quickly problems are caught once products are already in households.